News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Protherics PLC and Advancell Start Acadra(TM) Clinical Study in B-cell Chronic Lymphocytic Leukaemia


1/11/2008 8:44:12 AM

London, UK; Brentwood, TN, US; 11 January 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, and its co-development partner, Advancell s.l. ("Advancell"), today announce that the first patient has now been enrolled in a recently initiated phase 1/2 clinical study of Acadra(TM) (acadesine) in B-cell chronic lymphocytic leukaemia (B-CLL).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES